ClinConnect ClinConnect Logo
Search / Trial NCT02024048

Evaluation of Choroidal Thickness During Pregnancy Using Enhanced Depth Imaging Optical Coherence Tomography

Launched by GAIA HOSPITAL · Dec 30, 2013

Trial Information

Current as of May 27, 2025

Unknown status

Keywords

Pregnancy Oct Enhanced Depth Imaging Choroid

ClinConnect Summary

Pregnant women in the last trimester and age-matched healthy controls have an Optical Coherence Tomography (OCT) image taken on the OCT Spectralis® device.

A map of the choroid in the macular area is constructed automatically. Choroidal thickness and volume are calculated for the 9 subfields defined by the Early Treatment Diabetic Retinopathy Study (ETDRS).

A comparative analysis between the two groups will be performed. As a secondary outcome measure, the change in choroidal thickness of the pregnant group of women will be assessed at 6 months postpartum by comparison to the 3rd trimeste...

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • Pregnant women:
  • uncomplicated pregnancy in the third trimester (from 28 weeks of gestation)
  • For both groups:
  • no systemic or ocular disease
  • absence of systemic medication other than prenatal vitamins
  • no smoking habits
  • emmetropia or a small refractive error (spherical equivalent \<1.5 diopters)
  • Exclusion Criteria:
  • any of the above

About Gaia Hospital

Gaia Hospital is a leading clinical trial sponsor dedicated to advancing medical research and enhancing patient care through innovative studies. With a focus on ethical practices and patient safety, Gaia Hospital collaborates with healthcare professionals and institutions to design and execute rigorous clinical trials across various therapeutic areas. Committed to generating high-quality data, the organization employs cutting-edge methodologies and technologies to facilitate the development of new therapies and improve health outcomes. Through its relentless pursuit of excellence, Gaia Hospital strives to contribute significantly to the global medical community and foster a healthier future for all.

Locations

Vila Nova De Gaia, , Portugal

Patients applied

0 patients applied

Trial Officials

Renata Rothwell, Dr

Principal Investigator

Department of Opthalmolgy, Centro Hospitalar Vila Nova de Gaia/Espinho

Sofia Fonseca, Dr

Principal Investigator

Department of Ophthalmology, Centro Hospitalar Vila Nova de Gaia/Espinho

Marisa Oliveira, Dr

Principal Investigator

Department of Ophthalmology, Centro Hospitalar Vila Nova de Gaia/Espinho

Lígia Ribeiro, Dr

Principal Investigator

Department of Ophthalmology, Centro Hospitalar Vila Nova de Gaia/Espinho

Dália Meira, Dr

Principal Investigator

Department of Ophthalmology, Centro Hospitalar Vila Nova de Gaia/Espinho

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials